Recent 13F filings as of September 2025 show that 98 institutional investors hold a position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 30 Sep, 2025 | 13,959,973 | 0 | 0.00% | $21,079,559.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,904,400 | 19,768 | 0.69% | $4,385,644.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 2,845,152 | 46,132 | 1.65% | $4,291.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 2,325,355 | 795,802 | 52.03% | $3,511,286.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 2,077,290 | 2,077,290 | 0.00% | $3,136,708.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 1,550,000 | 0 | 0.00% | $2,340,500.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 1,548,781 | 835,466 | 117.12% | $2,338,660.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 1,461,200 | 185,286 | 14.52% | $2,206,412.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 1,408,803 | 211,179 | 17.63% | $2,127,292.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 1,407,829 | 310,178 | 28.26% | $2,125,823.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 1,363,347 | 270,294 | 24.73% | $2,058,654.00 |
| Decheng Capital LLC | 30 Sep, 2025 | 1,323,327 | 0 | 0.00% | $1,998,224.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 1,249,504 | -492,243 | -28.26% | $1,886,752.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 30 Sep, 2025 | 1,185,521 | 214,659 | 22.11% | $1,790,137.00 |
| GSA CAPITAL PARTNERS LLP | 30 Sep, 2025 | 1,077,656 | -55,719 | -4.92% | $1,627.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 30 Sep, 2025 | 962,620 | -65,000 | -6.33% | $1,453,556.00 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 30 Sep, 2025 | 961,486 | -516,666 | -34.95% | $1,451,844.00 |
| PFIZER INC | 30 Sep, 2025 | 953,834 | 0 | 0.00% | $1,440,289.00 |
| Almitas Capital LLC | 30 Sep, 2025 | 914,644 | -684,622 | -42.81% | $1,381,112.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 902,521 | -2,574,287 | -74.04% | $1,362,807.00 |